Articles On Cann Group (ASX:CAN)

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX seesaws between -0.5% and +1% to finish up +0.25% Energy fades into red as materials makes a comeback Tyro says RBA card surcharge ban could be an opportunity Market whipsaw as Trump floats potential end to war The S&P ASX 200 nee...

Highlights Market sentiment shifts from cautious to risk-on during session Technology stocks lead rebound while energy softens Consumer confidence concerns weigh on retail-linked sectors The ASX 200 reversed early losses to trade...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX lifts from lows of -1.5% to slide -0.65 Energy, utilities, materials, consumer staples make gains Banks and info tech retreat sharply   Aluminium and gold gains limit losses The S&P/ASX 200 had fallen 0.65% by trade’s end, shoved...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX retreats from early rally to add just 0.16% Traders react with scepticism to Trump’s Iranian assurances Materials sector snaps four-day losing streak, still down -20.2% from highs   Markets go hungry It seems the S&P/ASX 200 was l...

ASX rises 0.36% after falling into negative territory just before the RBA decision RBA votes to rase cash rate to 4.1% in 5v4 split decision Real estate and gold stocks lead gains RBA hikes rates in split decision The Reserve Bank did exa...

ASX healthcare sector falls 13.31% in February as benchmark ASX 200 up 4% Blood products and vaccines giant CSL weighed heavily on sector down 19.1% in February Rhythm Biosciences up 48% in February to be sector’s biggest gainer for the mo...

ASX closes flat, down just 0.04% to 9,022.30 points Tech stocks slump for second straight session BHP pushes through $55 for the first time    The ASX closed relatively flat, down 3.70 points or ~0.04% to 9,022.30 after Wall Street’s over...

The ASX closed 0.5% lower on Friday but at least it remained up for the week Energy best performing sector on ASX today as oil price rises on Middle East tensions Mixed day of earnings with QBE Insurance and Telix Pharmaceuticals posting s...

The ASX 200 gained 0.22% to kick off the week, with tech rebounding from last week’s sell-off The materials sector continued its recent volatility, dropping 1.04%, with large caps under pressure Eden Innovations climbed 37% after strategic...

ASX 200 closes 1.66% higher to 9,014.80, setting a new 50-day high CBA rises more than 7% after posting $5.45 billion profit for H1 FY26  Healthcare giant CSL falls 5.75% after its latest half-year results    It was a tale of two heavywei...

ASX healthcare sector rises 2.25% in January as benchmark ASX 200 up 1.78% Index largely supported by the sector’s largest stock CSL, up 5.1% in January Anteris and PYC announce monster capital raises with strong support from US investors...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX recovers from session lows of -0.84% to dip just -0.07% Info Tech extends losses, falling to Feb 2024 levels Uranium and gold stocks fuel materials and energy gains   Tech in harsh retreat The struggling info tech sector took another...

ASX climbs 0.48% in strong performance Nine of 11 sectors higher with 133/200 stocks climbing Most metals rally in solid commodity gain   Market powers higher in final hour The ASX 200 had a steady day of trade firmly above the line today...

ASX climbs 0.15% on solid breadth with 143 stocks rising 8 of 11 sectors higher, led by info tech Banks retreat despite cooling inflation read Rare Earth export restrictions spotlights ASX stocks The ASX 200 finished up 0.15% or 12.8 poin...

With the sun setting on another ‘issues rich’ year for ASX biotechs, Dr Boreham applies his stethoscope to the soaring highlights and cratering lowlights.   As usual we adopt the user-friendly A to Z format. If only drug, device and diagnos...

ASX 200 falls 0.16% or 13.7 points 10 of 11 sectors down with 98 stocks lower and 93 rising Materials alone in the green as XGD touches new record high   Gold and lithium stocks resist the tide A familiar game of tug-of-war played out on...

Opthea opts to pursue a rare lung disease known as LAM ECS Botanics prepares for a whiff of change for US cannabis laws federally Island Pharma strikes a key agreement to carry out US primate trial   Opthea (ASX:OPT) expects its shares to...

Medicinal cannabis company Cann Group (ASX: CAN) has successfully restructured its debt position from almost $75 million down to just $14.45 million after longstanding lender National Australia Bank (ASX: NAB) agreed to forgive debt in exch...

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

ASX adds just 14.5 points in subdued day of trade Broad rally in commodity prices lifts resource stocks Crude oil bounces 1.3% as Ukraine continues to strike Russian oil infrastructure   ASX grinds higher on commodity strength A fresh att...

Two dozen esteemed sector figures recently gathered over lunch to recount their career highs and lows One luminary recalls an uncomfortable close encounter with a drug cartel, while others overcame the impact of academic and corporate frau...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

Investors are stumping up cash for life sciences capital raisings – but the stories need to be well presented After an “incredibly tumultuous” nine months, fundraisings are on track to meet last year’s bumper tally of $2.9 billion Two medt...

The latest quarterlies show that key drug and diagnostics developers are well funded for the task Cann Group enters company-saving debt and equity restructuring deal A rebirth for Monash IVF?      Today’s crop of quarterly reports shows t...

ASX bounces off lows of -0.5pc to add two points Energy, defensive sectors and resources fuel gains Gold back in favour, even as prices remain subdued   Resources stocks fuel recovery The ASX was cruising for a bruising today, down 0.5%...

Highlights Discover the best workplaces for career growth in Australia. Learn about key skills and job functions in demand. Explore opportunities across multiple industries. Explore the 25 best workplaces in Australia for career g...

Highlights Discover the best workplaces for career growth in Australia. Learn about key skills and job functions in demand. Explore opportunities across multiple industries. Explore the 25 best workplaces in Australia for career g...

A Victorian man has been sentenced to 11 months imprisonment and ordered to pay a penalty of more than $225,000 after pleading guilty to insider trading charges involving a $20 million capital raise by medicinal cannabis company Cann Group...

Highlights US CBD comments influence global cannabis sentiment ASX cannabis companies may benefit from regulatory shifts Australian medicinal cannabis landscape gains attention Explore how recent US CBD developments impact ASX-lis...

ASX up 75 points to 8862.8 with 9 sectors higher Healthcare, banks and gold stocks drive gains Energy, info tech languish in the red   ASX pushes higher alongside spot gold The ASX 200 hummed higher throughout the day, closing out up 0.86...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX tips up just 0.1pc with eight sectors lower Energy, resources lead gains, outweighing losses Drop in gold price overnight undercuts gold index Copper comes out on top Move over gold, it’s copper’s turn to shine. With gold futures mov...

NZ drug maker’s expansion plans are no Aft-erthought Cann Group returns to profits – in August at least Veteran Sonic Healthcare chief calls it a day   Kiwi drug maker and distributor AFT Pharmaceuticals (ASX:AFP) is on track to achieve...

Ramsay says its full-year earnings met investors’ expectations – and if anything, were a tad higher Pacific Edge wins higher US reimbursement – but there’s a catch Leading up to AGMs, biotechs do the boardroom blitz   The ASX’s corporate...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

ASX rebounds to set new intraday high, up 0.53pc Origin Energy leads gains alongside utilities sector Unemployment rate falls, lowering interest rate cut chances   ASX sets new intraday high The ASX rebounded powerfully from yesterday’s p...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

ASX ends day on new record high at 8597 points 10 of 11 sectors higher with broad strength across market Materials leads gains, up 1.38pc   ASX almost breaks through 8600-point ceiling The ASX 200 had one of its best trading days in month...

Doctor visits dipped in April, reversing a recovery trend Mayne Pharma threatens to go legal in takeover dispute … but peace erupts at Cann Group with settlement of legal spat   We’re either a healthy lot, rely on Dr Google or simply can’...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

Highlights Surge in prescriptions for medical cannabis is accelerating domestic production and diversification Regulatory advancements enabling broader patient access and product innovation Australia emerging as a regional h...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

Australia’s S&P/ASX 200 rallies 3.62% in April, showing resilience to global geopolitical and economic uncertainty Ten out of 11 sectors post gains in April, led by communications up 6.47% followed by a 6.37% comeback from tech DY6 Met...

ASX falls 0.82pc, led down by energy and healthcare stocks Gold rises to all-time high at US$3,215 per ounce Oil falls to levels not seen since April 2020, at height of Covid-19 pandemic Despite pulling back on Tuesday, gold prices have h...

Highlights: ASX lifts sharply with all sectors closing higher, rebounding from prior session declines Nikkei records strong movement as markets respond to tariff rhetoric Resource and tech firms lead gains, while a few small...